New Techniques in Robotic Surgical Management of Mitral Valve Repair

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 23 April 2024

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cardio-Thoracic Surgery, Henri-Mondor University Hospital, Créteil, France
Interests: mini invasive surgery; robotic surgery; mitral valve repair; atrial fibrillation

E-Mail Website
Guest Editor
Department of Cardiac Surgery, Na Homolce Hospital, Prague, Czech Republic
Interests: robotic cardiac surgery; surgery of arrhytmias; mitral valve repair; aortic surgery; minimally invasive mitral valve surgery; myocardial protection

E-Mail Website
Guest Editor
Cardiac Surgery, Normandie University, Rouen University Hospital, Rouen, France
Interests: cardiac; aorta; aortic valve disease; mechanical circulatory assistance; minimally invasive; mitral valve disease; robotic; heart transplant

E-Mail Website
Guest Editor
Department of Cardio-Vascular Surgery, Vienna North Hospital and Karl Landsteiner Institute for Cardio-Vascular Research, Vienna, Austria
Interests: minimally invasive cardiac surgery

Special Issue Information

Dear Colleagues,

Robotic cardiac surgery was developed to offer the least invasive approach to managing a diverse array of cardiac conditions. It now encompasses mitral valve surgery, coronary revascularization, arrhythmia surgery, pacing lead implantation, congenital cardiac operations, cardiac tumour resections and diaphragmatic pacing. However, the adoption of robotic technology in the current clinical practice is not as widespread as initially anticipated, due to several negative drivers and constraints. There is a lack of robust evidence and a paucity of information from randomized controlled trials to support the wider application of robotic interventions within the current surgical climate.

The issue of adoption is quite complex and multifaceted, due to challenges in training, quality regulation, cost, service delivery and evidence provision. These have to be surmounted if totally endoscopic robotic approaches are to become first line therapies in the management of coronary and mitral disease. The ultimate role of robotic cardiac surgery is to translate scientific and engineering advances for the improvement of patient care. The possibilities offered by this technology present substantial operative versatility for 21st century healthcare. The future of robotic cardiac surgery depends on a united multidisciplinary dialogue between patients, cardiologists and surgeons to deliver these innovative procedures for appropriately selected individuals, with the primary aim of delivering the highest quality of care for cardiac patients.

Dr. Thierry Folliguet
Dr. Stepan Cerny
Dr. Fabien Doguet
Dr. Johannes Bonatti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Robotic surgery
  • Mitral valve repair
  • Mitral insufficiency
  • Minimal invasive surgery

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 878 KiB  
Article
Starting A New Robotic Surgery Program for Mitral Valve Repair. Lessons Learned from The First Nine Months
by Antonio Piperata, Olivier Busuttil, Nicolas d’Ostrevy, Jean-Luc Jansens, Saud Taymoor, Besart Cuko, Thomas Modine, Mathieu Pernot and Louis Labrousse
J. Clin. Med. 2021, 10(22), 5439; https://doi.org/10.3390/jcm10225439 - 21 Nov 2021
Cited by 5 | Viewed by 2062
Abstract
(1) Background: Although transcatheter technology is rapidly growing and represents a promising strategy, the surgical approach remains the best way to repair a degenerative mitral valve regurgitation. In this context, robotic surgery is technologically the most advanced method of minimally invasive mitral valve [...] Read more.
(1) Background: Although transcatheter technology is rapidly growing and represents a promising strategy, the surgical approach remains the best way to repair a degenerative mitral valve regurgitation. In this context, robotic surgery is technologically the most advanced method of minimally invasive mitral valve repair. The aim of this study is to present the preliminary results of the initial single-center experience with a new robotic mitral valve repair program. (2) Methods: We retrospectively reviewed the records of patients who underwent robotic mitral valve repair at our Institution between January and September 2021. (3) Results: A total of 29 patients underwent mitral valve repair with annuloplasty and chordal implantation to treat degenerative mitral regurgitation. The procedure’s success was achieved in 97% of patients. The 30-day cardiac-related mortality was 0%. The median CPB and cross-clamp times were 189 and 111 min, respectively, with a progressive reduction from the beginning of the robotic program. (4) Conclusions: Considering all the limitations related to the small sample, the presented results of robotic mitral valve repair appear to be encouraging and acceptable. A careful patient selection, a dedicated team, and a robust experience in surgical mitral valve repair are the fundamentals to start a new robotic mitral surgery program. Full article
(This article belongs to the Special Issue New Techniques in Robotic Surgical Management of Mitral Valve Repair)
Show Figures

Figure 1

Back to TopTop